Jan Verheijen

900 total citations
8 papers, 357 citations indexed

About

Jan Verheijen is a scholar working on Molecular Biology, Physiology and Surgery. According to data from OpenAlex, Jan Verheijen has authored 8 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Physiology and 2 papers in Surgery. Recurrent topics in Jan Verheijen's work include Glycosylation and Glycoproteins Research (2 papers), Alzheimer's disease research and treatments (2 papers) and Pancreatic function and diabetes (2 papers). Jan Verheijen is often cited by papers focused on Glycosylation and Glycoproteins Research (2 papers), Alzheimer's disease research and treatments (2 papers) and Pancreatic function and diabetes (2 papers). Jan Verheijen collaborates with scholars based in United States, Belgium and Netherlands. Jan Verheijen's co-authors include Kristel Sleegers, Éva Morava, Tamás Kozicz, Peter Witters, Caroline Van Cauwenberghe, Jasper Van Dongen, Sebastiaan Engelborghs, Rik Vandenberghe, Elise Cuyvers and Peter Paul De Deyn and has published in prestigious journals such as Trends in Genetics, Mayo Clinic Proceedings and Alzheimer s & Dementia.

In The Last Decade

Jan Verheijen

7 papers receiving 353 citations

Peers

Jan Verheijen

MB

PHYSI

GENET

NEURO

IMMUN

Jia Zou China

Mauro Racaniello Italy

Céline Bellenguez France

Tara R. Hawkinson United States

Laura Beth McIntire United States

Jennifer Nolz United States

K. Czeloth Germany

Steven M. Carl United States

Marion C. Hogg Ireland

Christopher J. Holler United States

Jia Zou China

Jan Verheijen

168 ×0.8

MB

100 ×0.6

PHYSI

45 ×0.6

GENET

66 ×1.4

NEURO

66 ×1.5

IMMUN

Citations per year, relative to Jan Verheijen Jan Verheijen (= 1×) peers Jia Zou

Countries citing papers authored by Jan Verheijen

Since Specialization

Citations

This map shows the geographic impact of Jan Verheijen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Verheijen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Verheijen more than expected).

Fields of papers citing papers by Jan Verheijen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Verheijen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Verheijen. The network helps show where Jan Verheijen may publish in the future.

Co-authorship network of co-authors of Jan Verheijen

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Verheijen. A scholar is included among the top collaborators of Jan Verheijen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Verheijen. Jan Verheijen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Paldino, Alessia, Jan Verheijen, John R. Giudicessi, et al.. (2024). Prevalence, Penetrance, and Phenotypic Manifestation of Cardiomyopathy-Associated Genetic Variants in the General Population: Insights from a Mayo Clinic Biobank Study. Mayo Clinic Proceedings. 99(11). 1732–1743. 1 indexed citations

2.

Iyer, Sangeetha, Nina DiPrimio, Graeme Preston, et al.. (2019). Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG. Disease Models & Mechanisms. 12(11). 44 indexed citations

3.

Verheijen, Jan, et al.. (2019). Therapeutic approaches in Congenital Disorders of Glycosylation (CDG) involving N-linked glycosylation: an update. Genetics in Medicine. 22(2). 268–279. 70 indexed citations

4.

Balakrishnan, Bijina, Jan Verheijen, Kimiyo Raymond, et al.. (2019). A novel phosphoglucomutase‐deficient mouse model reveals aberrant glycosylation and early embryonic lethality. Journal of Inherited Metabolic Disease. 42(5). 998–1007. 10 indexed citations

5.

Verheijen, Jan & Kristel Sleegers. (2018). Understanding Alzheimer Disease at the Interface between Genetics and Transcriptomics. Trends in Genetics. 34(6). 434–447. 133 indexed citations

6.

Aschrafi, Armaz, Jan Verheijen, Miklós Palkovits, et al.. (2016). MicroRNA-326 acts as a molecular switch in the regulation of midbrain urocortin 1 expression. Journal of Psychiatry and Neuroscience. 41(5). 342–353. 28 indexed citations

7.

Sleegers, Kristel, Karolien Bettens, Arne De Roeck, et al.. (2015). A 22‐single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Aβ₄₂. Alzheimer s & Dementia. 11(12). 1452–1460. 71 indexed citations

8.

Bettens, Karolien, Caroline Van Cauwenberghe, Elise Cuyvers, et al.. (2014). O4‐04‐03: HIGH SCORES ON A 22‐GENE RISK SCORE FOR ALZHEIMER'S DEMENTIA CORRELATE WITH EARLIER ONSET AGE AND REDUCED CSF Aβ. Alzheimer s & Dementia. 10(4S_Part_4).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact